Suchergebnisse - "Neurath, Markus F"

PubPharm (27)

1

Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells

enthalten in: Nature communications | 2024

von Wiendl, M. | Dedden, M. | Liu, L. | +12

2

Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2023

von Schulze, L. | Becker, E. | Dedden, M. | +18

3

Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease

enthalten in: Translational research : the journal of laboratory and clinical medicine | 2023

von Schneider, I. | Allner, C. | Mühl, L. | +12

4

Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab

enthalten in: Gut | 2022

von Becker, E. | Dedden, M. | Gall, C. | +12

CommentIn: Gut. 2022 Aug;71(8):1455-1456. - PMID 34497148

5

Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets

enthalten in: Clinical and translational gastroenterology | 2022

von Becker, E. | Schweda, A. | Ullrich, K. | +6

6

Vedolizumab-associated enthesitis : correlation or causality?

enthalten in: Rheumatology (Oxford, England) | 2021

von Vitali, F. | Simon, D. | Neurath, M. | +2

CommentOn: Rheumatology (Oxford). 2021 Dec 1;60(12):5809-5813. - PMID 33580246

7

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients : a cohort study

enthalten in: BMC gastroenterology | 2021

von Mühl, L. | Becker, E. | Müller, T. | +4

8

Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis : a cohort study

enthalten in: BMC gastroenterology | 2020

von Allner, C. | Melde, M. | Becker, E. | +11

9

Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing

enthalten in: Gut | 2020

von Schleier, L. | Wiendl, M. | Heidbreder, K. | +16

CommentIn: Gut. 2020 Jul;69(7):1359-1361. - PMID 31201286

10

Anti-trafficking agents in the treatment of inflammatory bowel disease

enthalten in: Current opinion in gastroenterology | 2019

von Zundler, S. | Wiendl, M. | Neurath, M.